Cargando…

Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.

Seventeen alkylamine ammine dicarboxylatodichloroplatinum(IV) complexes of general structure c,t,c-[PtCl2(OCOR1)2NH3(RNH2)], where R = aliphatic or alicyclic and R1 = aliphatic or aromatic, have been evaluated against L1210 cell lines with acquired resistance to cisplatin (10-fold), tetraplatin (34-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orr, R. M., O'Neill, C. F., Nicolson, M. C., Barnard, C. F., Murrer, B. A., Giandomenico, C. M., Vollano, J. F., Harrap, K. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033379/ https://www.ncbi.nlm.nih.gov/pubmed/8080724

Ejemplares similares

Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.
por: McKeage, M. J., et al.
Publicado: (1993)

The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
por: Ormerod, M. G., et al.
Publicado: (1996)

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.
por: Loh, S. Y., et al.
Publicado: (1992)

Characterization of a monoclonal antibody to L1210 leukaemia.
por: Testorelli, C., et al.
Publicado: (1982)

Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
por: McKeage, M. J., et al.
Publicado: (1994)

Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.
por: Hacker, M., et al.
Publicado: (1980)

Development of cyclosporin A mediated immunity in L1210 leukaemia.
por: Slater, L. M., et al.
Publicado: (1991)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

De Novo Generation of Singlet Oxygen and Ammine Ligands by Photoactivation of a Platinum Anticancer Complex**
por: Zhao, Yao, et al.
Publicado: (2013)

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
por: Mathé, G., et al.
Publicado: (1969)

Influence of micrococcus, BCG and related polysaccharides on the proliferation of the L1210 leukaemia.
por: Verloes, R., et al.
Publicado: (1978)

Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes
por: Betanzos-Lara, Soledad, et al.
Publicado: (2011)

Facile Uptake and Release of Ammonia by Nickel Halide Ammines
por: Breternitz, Joachim, et al.
Publicado: (2016)

Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody.
por: Testorelli, C., et al.
Publicado: (1983)

Haematological toxicity of carboplatin in rats.
por: Siddik, Z. H., et al.
Publicado: (1987)

Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
por: Akamatsu, K., et al.
Publicado: (1992)

Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex.
por: O'Neill, C. F., et al.
Publicado: (1996)

Adenosine deaminase activity in leukaemia.
por: Smyth, J. F., et al.
Publicado: (1975)

Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.
por: Verloes, R., et al.
Publicado: (1981)

DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells.
por: Dean, S. W., et al.
Publicado: (1985)

5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
por: Roobol, C., et al.
Publicado: (1984)

A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-α and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice
por: Warzocha, K., et al.
Publicado: (1994)

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
por: Duncan, R., et al.
Publicado: (1988)

Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow.
por: Tapazoglou, E., et al.
Publicado: (1991)

Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8).
por: Peckham, M. J., et al.
Publicado: (1985)

Some Biochemical Aspects of Leukaemias: The Appearance of a Soluble Disulphide in the Blood in Chronic Granulocytic Leukaemia
por: Harrap, K. R., et al.
Publicado: (1964)

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
por: Wagner, U, et al.
Publicado: (2012)

The influence of 2- chlorodeoxyadenosine in combination with tumour necrosis factor-α or its mutein on murine leukaemias L1210 and P388
por: Góra-Tybor, J., et al.
Publicado: (1995)

In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.
por: Camplejohn, R. S., et al.
Publicado: (1977)

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.
por: Holford, J., et al.
Publicado: (1998)

Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
por: Jones, M., et al.
Publicado: (1993)

Homolytic N–H Activation of Ammonia: Hydrogen Transfer of Parent Iridium Ammine, Amide, Imide, and Nitride Species
por: Scheibel, Markus G., et al.
Publicado: (2015)

Criteria for the selection of second-generation platinum compounds.
por: Shepherd, R., et al.
Publicado: (1980)

Successful Treatment with Pemetrexed, Carboplatin, and Bevacizumab for Platinum-Resistant Adenocarcinoma of the Lung
por: Wada, Sae, et al.
Publicado: (2012)

Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer
por: McMeekin, S, et al.
Publicado: (2012)

Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours
por: Veal, G J, et al.
Publicado: (2007)

The Uptake and Utilization of Chlorambucil by Lymphocytes from Patients with Chronic Lymphocytic Leukaemia
por: Hill, Bridget T., et al.
Publicado: (1972)

Efficacy of birinapant in combination with carboplatin in targeting platinum-resistant epithelial ovarian cancers
por: Singh, Tanya, et al.
Publicado: (2022)

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997)

L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives.
por: Geroni, C., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_4rmc694vktas0c3sfkmtgfhv3f